Please assess the completion status of the following clinical trial:

Trial Title: Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female subject of any ethnic background of 12 years or older.~* Subject with mild or moderate facial acne vulgaris defined as an Investigator Global Assessment (IGA) score at 2 or 3 on a 0-4 scale.~* Subject with any skin phototype according to T.B. Fitzpatrick skin phototype definitions.~Exclusion Criteria:~* Subject with severe acne (IGA\>3) with nodules, cysts, scars or extra-facial lesions,~* Female subject who is pregnant, lactating or planning a pregnancy during the study,~* Subject susceptible to take a corticosteroid treatment during the study except inhaled or topic when needed to treat a condition outside the face,

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Benzaknen treatment regimen (Type: EXPERIMENTAL): Benzac® 5% Gel (once daily) + Dermotivin® Soft Liquid soap (twice daily) + Cetaphil® Dermacontrol Moisturizer SPF30 (once daily)

Based on this trial design, predict the completion outcome and termination type (if applicable).